Search Within

Yanming Zhang

  1. "Biostatistics Service"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (16)
  3. Research Letter (5)
Groups
  1. Biostatistics Service (41)
  2. Department of Pathology and Laboratory Medicine (41)
  3. Epidemiology and Biostatistics (41)
  4. Department of Medicine (40)
  5. Hematologic Malignancies, Division of (37)
  6. Center for Hematologic Malignancies (36)

More Groups

People
  1. Andriy Derkach (20)
  2. Ross Levine (17)
  3. Maria Arcila (16)
  4. Ahmet Dogan (15)
  5. Martin Tallman (15)
  6. Mikhail Roshal (15)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (10)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Blood (15)
  2. Blood Advances (4)
  3. Nature Communications (4)
  4. American Journal of Hematology (2)
  5. Clinical Cancer Research (2)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (19)
  2. Nature Publishing Group (6)
  3. American Association for Cancer Research (3)
  4. Elsevier Inc. (2)
  5. Elsevier Ltd (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial whole genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Meeting Abstract

    Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; Iacobuzio-Donahue, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Research Letter

    Bernard, E.; Nannya, Y.; Hasserjian, R. P.; Devlin, S. M.; Tuechler, H.; Medina-Martinez, J. S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes
    Journal Article

    Menghrajani, K.; Zhang, Y.; Famulare, C.; Devlin, S. M.; Tallman, M. S.
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Journal Article

    Sermer, D.; Bobillo, S.; Dogan, A.; Zhang, Y.; Seshan, V.; Lavery, J. A.; Batlevi, C.; Caron, P.; Hamilton, A.; Hamlin, P.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients
    Meeting Abstract

    Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
    Blood (2019)

    Fulltext@MSK | Save
  • TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Bernard, E.; Nannya, Y.; Yoshizato, T.; Hasserjian, R. P.; Saiki, R.; Shiozawa, Y.; Devlin, S. M.; Tuechler, H.; Sarian, A.; Malcovati, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save